Hepatic Stellate Cell-Immune Interactions in NASH

被引：51

作者：

Carter, James K. ^{[1
,2
]}

Friedman, Scott L. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Med Scientist Training Program, New York, NY USA

来源：

FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷

基金：

美国国家卫生研究院;

关键词：

hepatic stellate cells; NASH; inflammation; fibrosis; immunity; ANTIGEN-PRESENTING CELLS; FATTY LIVER-DISEASE; REGULATORY T-CELLS; KUPFFER CELLS; NONALCOHOLIC STEATOHEPATITIS; DENDRITIC CELLS; B-CELLS; FIBROSIS; INFLAMMATION; ACTIVATION;

D O I：

10.3389/fendo.2022.867940

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nonalcoholic fatty liver disease (NAFLD) is the dominant cause of liver disease worldwide. Nonalcoholic steatohepatitis (NASH), a more aggressive presentation of NAFLD, is characterized by severe hepatocellular injury, inflammation, and fibrosis. Chronic inflammation and heightened immune cell activity have emerged as hallmark features of NASH and key drivers of fibrosis through the activation of hepatic stellate cells (HSCs). Recent advances in our understanding of the molecular and cellular pathways in NASH have highlighted extensive crosstalk between HSCs and hepatic immune populations that strongly influences disease activity. Here, we review these findings, emphasizing the roles of HSCs in liver immunity and inflammation, key cell-cell interactions, and exciting areas for future investigation.

引用

页数：12

共 151 条

[41] Lytic cell death in metabolic liver disease [J].

Gautheron, Jeremie ;

Gores, Gregory J. ;

Rodrigues, Cecilia M. P. .

JOURNAL OF HEPATOLOGY, 2020, 73 (02) :394-408

[42] Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome [J].

Ghazarian, Magar ;

Revelo, Xavier S. ;

Nohr, Mark K. ;

Luck, Helen ;

Zeng, Kejing ;

Lei, Helena ;

Tsai, Sue ;

Schroer, Stephanie A. ;

Park, Yoo Jin ;

Chng, Melissa Hui Yen ;

Shen, Lei ;

D'Angelo, June Ann ;

Horton, Peter ;

Chapman, William C. ;

Brockmeier, Diane ;

Woo, Minna ;

Engleman, Edgar G. ;

Adeyi, Oyedele ;

Hirano, Naoto ;

Jin, Tianru ;

Gehring, Adam J. ;

Winer, Shawn ;

Winer, Daniel A. .

SCIENCE IMMUNOLOGY, 2017, 2 (10)

[43] Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC [J].

Grohmann, Marcus ;

Wiede, Florian ;

Dodd, Garron T. ;

Gurzov, Esteban N. ;

Ooi, Geraldine J. ;

Butt, Tariq ;

Rasmiena, Aliki A. ;

Kaur, Supreet ;

Gulati, Twishi ;

Goh, Pei K. ;

Treloar, Aislinn E. ;

Archer, Stuart ;

Brown, Wendy A. ;

Muller, Mathias ;

Watt, Matthew J. ;

Ohara, Osamu ;

McLean, Catriona A. ;

Tiganis, Tony .

CELL, 2018, 175 (05) :1289-+

[44] Functional Linkage of Cirrhosis-Predictive Single Nucleotide Polymorphisms of Toll-like Receptor 4 to Hepatic Stellate Cell Responses [J].

Guo, Jinsheng ;

Loke, Johnny ;

Zheng, Feng ;

Hong, Feng ;

Yea, Steven ;

Fukata, Masayuki ;

Tarocchi, Mirko ;

Abar, Olivia T. ;

Huang, Hongjin ;

Sninsky, John J. ;

Friedman, Scott L. .

HEPATOLOGY, 2009, 49 (03) :960-968

[45] Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity [J].

Gupta, Gaurav ;

Khadem, Forough ;

Uzonna, Jude E. .

CYTOKINE, 2019, 124

[46] NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis [J].

Gur, Chamutal ;

Doron, Sarit ;

Kfir-Erenfeld, Shlomit ;

Horwitz, Elad ;

Abu-tair, Lina ;

Safadi, Rifaat ;

Mandelboim, Ofer .

GUT, 2012, 61 (06) :885-893

[47] Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution [J].

Haas, Joel T. ;

Vonghia, Luisa ;

Mogilenko, Denis A. ;

Verrijken, An ;

Molendi-Coste, Olivier ;

Fleury, Sebastien ;

Deprince, Audrey ;

Nikitin, Artemii ;

Woitrain, Eloise ;

Ducrocq-Geoffroy, Lucie ;

Pic, Samuel ;

Derudas, Bruno ;

Dehondt, Helene ;

Gheeraert, Celine ;

Van Gaal, Luc ;

Driessen, Ann ;

Lefebvre, Philippe ;

Staels, Bart ;

Francque, Sven ;

Dombrowicz, David .

NATURE METABOLISM, 2019, 1 (06) :604-614

[48] Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD [J].

Hagstrom, Hannes ;

Nasr, Patrik ;

Ekstedt, Mattias ;

Hammar, Ulf ;

Stal, Per ;

Hultcrantz, Rolf ;

Kechagias, Stergios .

JOURNAL OF HEPATOLOGY, 2017, 67 (06) :1265-1273

[49] Chemokine Receptor CCR6-Dependent Accumulation of γδ T Cells in Injured Liver Restricts Hepatic Inflammation and Fibrosis [J].

Hammerich, Linda ;

Bangen, Joerg M. ;

Govaere, Olivier ;

Zimmermann, Henning W. ;

Gassler, Nikolaus ;

Huss, Sebastian ;

Liedtke, Christian ;

Prinz, Immo ;

Lira, Sergio A. ;

Luedde, Tom ;

Roskams, Tania ;

Trautwein, Christian ;

Heymann, Felix ;

Tacke, Frank .

HEPATOLOGY, 2014, 59 (02) :630-642

[50] A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis [J].

Han, Yong-Hyun ;

Shin, Kyong-Oh ;

Kim, Ju-Yeon ;

Khadka, Daulat B. ;

Kim, Hyeon-Ji ;

Lee, Yong-Moon ;

Cho, Won-Jea ;

Cha, Ji-Young ;

Lee, Bong-Jin ;

Lee, Mi-Ock .

JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (04) :1684-1698

← 1 2 3 4 5 6 7 8 9 10 →